Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Efficacy of physical activity in the adjunctive treatment of major depressive disorders: preliminary results.

Pilu A, Sorba M, Hardoy MC, Floris AL, Mannu F, Seruis ML, Velluti C, Carpiniello B, Salvi M, Carta MG.

Clin Pract Epidemiol Ment Health. 2007 Jul 9;3:8.

2.

Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder.

Carta MG, Hardoy MC, Pilu A, Sorba M, Floris AL, Mannu FA, Baum A, Cappai A, Velluti C, Salvi M.

Clin Pract Epidemiol Ment Health. 2008 Jan 26;4:1. doi: 10.1186/1745-0179-4-1.

3.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
4.
5.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
6.

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E.

JAMA. 2000 Jun 21;283(23):3082-8.

PMID:
10865302
7.
8.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
9.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
10.

Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.

Mowla A, Kardeh E.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):970-3. doi: 10.1016/j.pnpbp.2011.01.016. Epub 2011 Feb 1.

PMID:
21291943
11.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
12.

Sertraline treatment of major depression in patients with acute MI or unstable angina.

Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M; Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group.

JAMA. 2002 Aug 14;288(6):701-9. Erratum in: JAMA 2002 Oct 9;288(14):1720.

PMID:
12169073
13.
14.

A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.

Vieta E, Manuel Goikolea J, Martínez-Arán A, Comes M, Verger K, Masramon X, Sanchez-Moreno J, Colom F.

J Clin Psychiatry. 2006 Mar;67(3):473-7.

PMID:
16649836
15.

Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.

CNS Drugs. 2011 Mar;25(3):227-38. doi: 10.2165/11586460-000000000-00000.

PMID:
21323394
16.

Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis.

Na KS, Lee KJ, Lee JS, Cho YS, Jung HY.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:79-85. doi: 10.1016/j.pnpbp.2013.09.006. Epub 2013 Sep 20. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:136.

PMID:
24056287
17.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
18.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
19.

Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.

Narendran R, Young CM, Valenti AM, Pristach CA, Pato MT, Grace JJ.

J Clin Psychiatry. 2001 Jul;62(7):509-16.

PMID:
11488360
20.

Effectiveness of St John's wort in major depression: a randomized controlled trial.

Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U.

JAMA. 2001 Apr 18;285(15):1978-86.

PMID:
11308434

Supplemental Content

Support Center